OVERVIEW

Updates on the Management of Insomnia: Expert Guidance Through the Latest Clinical Trials on Dual Orexin Receptor Antagonists is organized by CME Outfitters, LLC.

Premiere Date: Tuesday, June 16, 2020
Credit Expiration Date: Wednesday, June 16, 2021

Target Audience
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other non-physician healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.

This activity offers CE credit for:
• Physicians (CME)
• Pharmacists (ACPE)
• Other

Credit Information:
CME Credit (Physicians):
CME Outfitters designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .75 contact hours (0.75 CEUs)

Statement of Need:
This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 - 29, 2020.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Query your patients about insomnia to facilitate diagnosis and treatment to reduce the personal, clinical, and societal burden it imposes.
• Examine the role of orexin in sleep/wake regulation to facilitate treatment selection, particularly in the elderly and those with comorbid conditions.
• Incorporate clinical trial updates on dual orexin reuptake inhibitors to identify effective strategies to safely manage insomnia, particularly in older adults with high medical burden and poly pharmacy.